{"id":"W4396604922","doi":"10.1200/jco.23.00934","title":"Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Adaptive Biotechnologies; Astellas Pharma; bluebird bio; Kiadis Pharma; Omeros Corporation; Pfizer; Incyte; Jazz Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; BeiGene; HistoGenetics; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Celgene; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; GlaxoSmithKline; Amgen; Mallinckrodt Pharmaceuticals; Astellas Pharma US; National Institute of Allergy and Infectious Diseases; Roswell Park Cancer Institute","keywords":"Medicine; Minimal residual disease; Internal medicine; Multiple myeloma; Oncology; Hazard ratio; Lenalidomide; Hematopoietic stem cell transplantation; Transplantation; Progression-free survival; Surgery; Gastroenterology; Bone marrow; Overall survival; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001253952,0.0002115513,0.00041359,0.0002451207,0.0001787373,0.0004072684,0.0003097107,0.0003984565,0.0008738763],"category_scores_gemma":[0.001424928,0.000106052,0.0004664404,0.0002073047,0.0002567348,0.0003373147,0.0002862659,0.0005968863,0.000104341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002666799,"about_ca_system_score_gemma":0.0002222061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004774266,"about_ca_topic_score_gemma":0.0009543374,"domain_scores_codex":[0.9995978,0.0001285344,0.00003639772,0.0000803423,0.00009076649,0.00006619033],"domain_scores_gemma":[0.9984127,0.000301079,0.0008188868,0.00007517677,0.00004895309,0.0003431724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04590489,0.001054745,0.914074,0.0001147852,0.0006222131,0.00009704762,0.00006717062,0.0005364339,0.004563374,0.0001039616,0.0004652523,0.03239613],"study_design_scores_gemma":[0.0004767587,0.006654031,0.9902899,0.0000149437,0.0002467436,0.0002499442,0.00003456271,0.0006364222,0.0007411444,0.00009759832,0.0005484375,0.000009403763],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998575,0.0009516121,0.00007577545,0.00004702233,0.000008752986,0.000009923182,0.0001014253,0.000005538236,0.0002248585],"genre_scores_gemma":[0.9995185,0.00008026363,0.0000467458,0.00003444913,0.00001672059,0.000007587241,0.0001355283,9.442198e-7,0.0001593063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001253952,"threshold_uncertainty_score":0.006631613,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0611446475342914,"score_gpt":0.3903301810617518,"score_spread":0.3291855335274604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}